Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,532 | 274 | 98.3% |
| Education | $92.99 | 2 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $869.46 | 39 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $674.48 | 19 | $0 (2024) |
| Lilly USA, LLC | $586.98 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $512.53 | 18 | $0 (2024) |
| PFIZER INC. | $352.84 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $351.63 | 23 | $0 (2024) |
| Amgen Inc. | $294.47 | 14 | $0 (2024) |
| Horizon Therapeutics plc | $209.24 | 9 | $0 (2022) |
| Novo Nordisk Inc | $204.81 | 13 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $142.68 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,776 | 94 | ABBVIE INC. ($356.85) |
| 2023 | $1,796 | 86 | ABBVIE INC. ($512.61) |
| 2022 | $1,225 | 56 | Bayer HealthCare Pharmaceuticals Inc. ($213.82) |
| 2021 | $828.09 | 40 | AstraZeneca Pharmaceuticals LP ($294.71) |
All Payment Transactions
276 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PAIN | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: PAIN | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $115.48 | General |
| Category: Cardio-renal | ||||||
| 11/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Oncology | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Biological | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: UROLOGY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.97 | General |
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 267 | 301 | $47,947 | $15,148 |
| 2022 | 5 | 244 | 253 | $40,309 | $15,867 |
| 2021 | 5 | 241 | 268 | $54,190 | $26,065 |
| 2020 | 5 | 258 | 319 | $62,790 | $26,333 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 119 | $20,468 | $5,991 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 79 | $19,114 | $5,335 | 27.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $3,472 | $1,454 | 41.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 38 | 38 | $2,356 | $1,174 | 49.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,617 | $791.23 | 48.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $696.00 | $343.20 | 49.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 26 | 28 | $224.00 | $59.40 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 140 | $24,973 | $10,085 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 58 | $9,306 | $3,334 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,886 | $1,404 | 36.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 28 | 28 | $1,736 | $848.96 | 48.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 12 | 12 | $408.00 | $194.40 | 47.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 164 | 174 | $27,840 | $13,523 | 48.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 22 | 32 | $12,800 | $6,303 | 49.2% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 22 | 27 | $8,100 | $3,625 | 44.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 16 | $3,360 | $1,713 | 51.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 17 | 19 | $2,090 | $900.22 | 43.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 154 | 159 | $25,440 | $11,067 | 43.5% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 31 | 39 | $15,600 | $6,133 | 39.3% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2020 | 28 | 36 | $10,800 | $4,293 | 39.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 30 | 69 | $7,590 | $3,302 | 43.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 15 | 16 | $3,360 | $1,537 | 45.8% |
About Amy Claunch, APRN
Amy Claunch, APRN is a Nurse Practitioner healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2016. The National Provider Identifier (NPI) number assigned to this provider is 1861943029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Claunch, APRN has received a total of $5,625 in payments from pharmaceutical and medical device companies, with $1,776 received in 2024. These payments were reported across 276 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($5,532).
As a Medicare-enrolled provider, Claunch has provided services to 1,010 Medicare beneficiaries, totaling 1,141 services with total Medicare billing of $83,412. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Lexington, KY
- Active Since 10/21/2016
- Last Updated 07/01/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1861943029
Products in Payments
- VRAYLAR (Drug) $696.44
- Kerendia (Drug) $674.48
- MOUNJARO (Drug) $492.87
- NURTEC ODT (Drug) $271.96
- FARXIGA (Drug) $221.98
- KRYSTEXXA (Biological) $209.24
- LOKELMA (Drug) $206.07
- TRELEGY ELLIPTA (Drug) $172.63
- JARDIANCE (Drug) $169.03
- Parsabiv (Drug) $144.01
- GEMTESA (Drug) $142.68
- Velphoro (Drug) $131.14
- QULIPTA (Drug) $127.21
- JYNARQUE (Drug) $109.24
- Veltassa (Drug) $102.86
- SHINGRIX (Biological) $98.49
- SPRAVATO (Drug) $98.23
- Auvelity (Drug) $89.52
- Wegovy (Drug) $81.28
- BENLYSTA (Biological) $80.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Lexington
Rachael Bradford, Aprn, APRN
Nurse Practitioner — Payments: $369,931
Jessica Schorck, Aprn, APRN
Nurse Practitioner — Payments: $19,669
Juawanna Schuller, Arnp, ARNP
Nurse Practitioner — Payments: $19,426
Mrs. Megan Collett, Aprn, APRN
Nurse Practitioner — Payments: $10,839
Holly Chitwood, Aprn, APRN
Nurse Practitioner — Payments: $8,212
Robin Sutcliffe, Aprn, APRN
Nurse Practitioner — Payments: $8,003